Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P09 - Health Services Research/Health Economics - Real World Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 60
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.13 - Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab
00:00 - 00:00 | Presenter: Parthib Das
- Abstract
Loading...
-
+
P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC
- Type: Posters
- Track: Locoregional and Oligometastatic Disease
- Presentations: 17
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P21.02 - Incidence and Outcomes of Brain Metastases in Unresectable Stage III Patients with NSCLC Treated with Durvalumab after Chemoradiation
00:00 - 00:00 | Presenter: Sandip H Patel
- Abstract
Loading...
-
+
P48 - Small Cell Lung Cancer/NET - Chemo - IO
- Type: Posters
- Track: Small Cell Lung Cancer/NET
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P48.19 - Outcomes of Patients Treated with First Line Immunotherapy Plus Chemotherapy for ES-SCLC: Real World Outcomes from a Tertiary Academic Center
00:00 - 00:00 | Presenter: Sandip H Patel
- Abstract
Loading...
-
+
P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 22
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P75.12 - Prognostic Value of Neutrophil to Lymphocyte Ratio in NSCLC Patients Receiving First Line Immune Checkpoint Inhibitor Therapy
00:00 - 00:00 | Presenter: Nitya Surya
- Abstract
Loading...
-
+
P78 - Immunotherapy (Phase II/III Trials) - Immune Checkpoint Inhibitor Single Agent
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P78.05 - Patterns of irAE During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome
00:00 - 00:00 | Presenter: Cameron Champion Wood
- Abstract
Loading...
-
+
P79 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P79.04 - A Phase 2 Trial of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis.
00:00 - 00:00 | Presenter: Dwight H Owen
- Abstract
Loading...